Innovation is not enough: Translating life science innovations into tangible patient benefits requires corresponding innovation in the tools and methodologies that inform regulatory, reimbursement and clinical decisions about patient access and treatment. In this podcast, Dr. Hans-George Eichler, Senior Medical Officer for the European Medicines Agency, discusses innovation and related topics with DIA Global Forum Deputy Editor Dr. Alberto Grignolo.